Neos Therapeutics Reports First Quarter 2020 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Neos Therapeutics (NEOS) Misses Q1 EPS by 7c, Slight Miss on Revenues
May 11, 2020 5:19 PM EDTNeos Therapeutics (NASDAQ: NEOS) reported Q1 EPS of ($0.16), $0.07 worse than the analyst estimate of ($0.09). Revenue for the quarter came in at $14.49 million versus the consensus estimate of $14.55 million.
Since late 2018, we have been steadfast in taking action to better position Neos for long-term... More
